Resyca announces leadership changes
Resyca®, a leading provider of inhaler technology, announced today that Nicolas Buchmann, currently Resyca’s Head of Development and Project Management, will assume the role of Chief Technical Officer.
Nicolas brings extensive experience in the pharmaceutical industry and has played a pivotal role in the development of Resyca®’s PFSITM and PulmosprayTM platforms.
Nicolas Buchmann replaces Wilbur de Kruijf, who is leaving to embark on a new venture, as a customer of Resyca® through his company, Thaerapy BV. In his new role, he will utilize Resyca®’s soft mist inhaler technology to develop innovative combination products for the treatment of pulmonary hypertension.
“Nicolas will lead our technical team and drive continued innovation and growth at Resyca®,” said Bernhard Müllinger, Resyca®’s co-founder and current General Manager and COO. “With his expertise and our commitment to quality and customer satisfaction, we are well-positioned to continue providing innovative solutions to the pharmaceutical industry.”
“We are thrilled to continue our collaboration with Wilbur as a valued customer of Resyca®,” continues Bernhard Müllinger, “We believe his new venture will further showcase the effectiveness of our inhaler technology and help us to advance our mission of providing patients with innovative and effective treatment options.”
Founded in 2020 by Medspray and Recipharm, under the leadership of Wilbur de Kruijf and Bernhard Müllinger, Resyca® has rapidly emerged as a leading provider of inhaler technology, boasting several joint-development and licensing agreements with pharmaceutical partners. “We are grateful to Wilbur for his support and immense dedication to Resyca®, which has contributed to the successful development of our inhalers and the establishment of our current customer base,” expressed Bernhard Müllinger.
About Resyca®
Resyca® was founded in 2020 and is a joint venture between Bespak and Medspray. Resyca® specialises in the development and manufacturing of compact, user-friendly soft mist inhalation and soft nasal spray devices, incorporating the proprietary Medspray micro-nozzle technology. These devices are tailored for pulmonary and nasal applications, utilising standard pre-filled syringes / primary packaging and filling lines. As the soft mist development centre within Bespak, Resyca offers comprehensive services spanning from early-stage development through to commercial production, inclusive of filling, labelling, and packaging.
For further information and interview opportunities with Resyca®, please contact:
Bernhard Müllinger at Resyca BV
Email: info@resyca.com
Website: www.resyca.com
